Volume 19, Number 1—January 2013
Research
Microevolution of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Humans, Egypt, 2007–2011
Table
Protein, amino acid position |
Virus group†
|
Functional relevance (reference#) | |||||
---|---|---|---|---|---|---|---|
2.2.1-C | 9174‡ | 2009 variants§ | 2007–2008 variants¶ | A, B, and D | 2.2.1.1 | ||
PB2 | |||||||
80 |
R | R | R | R | K | K | NP binding site (17,18) |
129 |
N | N | N | N | T | T | |
292 |
M | M | I | I | I | I | No known function |
PB1 | |||||||
384 |
S | S | S | L | L | L | cRNA binding (19) |
PB1-F2 | |||||||
40 |
G | G | D/G | D | D | D | No known function |
PA | |||||||
400 |
T | T | S | S | S | S | No known function |
615 |
R | R | K/R | K | K | K | 615R mammalian host adaptation (20) |
HA | |||||||
43 |
N | N | N | N | D | D | Antigenic site C (21) |
120 |
N | N/D | N | N | S | S | No known function |
129 |
Del | Del | Del | Del | S | L/S | Near or adjacent to the receptor binding site 130-loop (21) |
151 |
T | T | T | T | I | I | Antigenic site B and receptor binding (21) |
NA | |||||||
224 |
M | M | M | L | L | L | No known function |
450 |
G | G | G | S | S | S | No known function |
M1 | |||||||
95 |
K | K | K | R | R | R | No known function |
168 |
T | T | I | I | I | I | RNP binding site (22) |
207 |
S | S | N | N | N | N | |
M2 | |||||||
51 |
F | F | C | C | C | C | No known function |
NS1 | |||||||
48 |
S | N | S | N | N | N | RNA binding site (23) |
198 |
V | V | I/V | I | I | I/V | Effector domain: inhibition of maturation and exportation of host antiviral mRNAs (23) |
229 |
E | E | K | K | K | K | PDZ ligand motif of HPAI equals ESEV (23,24) |
*Hemagglutinin (HA) amino acid numbering was based on the mature HA protein sequence after removal of the signal peptide. All other numbering was relative to the full-length open reading frame of A/goose/Guangdong/1/1996 protein sequences. PB2, polymerase basic 2 gene; NP, nucleoprotein; PB1, PB 1 gene; PB1-F2, alternate open reading frame near the 5′ end of the PB1 gene; PA, polymerase acidic gene; Del, deletion; NA, neuraminidase; M, matrix gene; RNP, ribonucleoprotein; NS, nonstructural gene; PDZ, postsynaptic density protein, Drosophila disk large tumor suppressor, and zonula occludens-1 protein; HPAI, highly pathogenic avian influenza; ESEV, H5N1 PDZ-binding motif amino acid consensus sequence.
†Boldface indicates unique amino acid differences found in the various positions along the different genes of 2.2.1-C viruses.
‡Indicates intraclade reassortant virus A/Egypt/9174-NAMRU3/2009.
§A/Egypt/0606-NAMRU3/2009, A/Egypt/2752-NAMRU3/2009, A/Egypt/3450-NAMRU3/2009.
¶Early 2.2.1-C viruses from 2007–2008: A/Egypt/394-NAMRU3/2007, A/Egypt/2546-NAMRU3/2008, A/Egypt/2289-NAMRU3/2008.
#References describing functional significance of mutations.
References
- Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A. (H5N1) Virus. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med. 2008;358:261–73. DOIPubMedGoogle Scholar
- Kandeel A, Manoncourt S, Abd el Kareem E, Mohamed Ahmed AN, El-Refaie S, Essmat H, Zoonotic transmission of avian influenza virus (H5N1), Egypt, 2006–2009. Emerg Infect Dis. 2010;16:1101–7. DOIPubMedGoogle Scholar
- Saad MD, Ahmed LS, Gamal-Eldein MA, Fouda MK, Khalil F, Yingst SL, Possible avian influenza (H5N1) from migratory bird, Egypt. Emerg Infect Dis. 2007;13:1120–1. DOIPubMedGoogle Scholar
- Food and Agriculture Organization. H5N1 HPAI global overview. 2009. Issue 14 [cited 2012 Nov 5]. http://www.fao.org/avianflu/en/overview.htm
- World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization H5N1 Evolution Working Group. Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: divergence of clade 2.2 viruses. Influenza Other Respir Viruses. 2009;3:59–62.
- World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization H5N1 Evolution Working Group. Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. Influenza Other Respir Viruses. 2012;6:1–5.
- World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003–2012. 2012 [cited 2012 Nov 5]. http://www.who.int/influenza/human_animal_interface/EN_GIP_20120208CumulativeNumberH5N1cases.pdf
- Kayali G, Webby RJ, Ducatez MF, El Shesheny RA, Kandeil AM, Govorkova EA, The epidemiological and molecular aspects of influenza H5N1 viruses at the human–animal interface in Egypt. PLoS ONE. 2011;6:e17730. DOIPubMedGoogle Scholar
- World Health Organization. Recommendations and laboratory procedures for detection of avian influenza A(H5N1) virus in specimens from suspected human cases. 2012 [cited 2012 Nov 5]. http://www.who.int/entity/influenza/resources/documents/h5n1_laboratory_procedures/en/index.html
- Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–7. DOIPubMedGoogle Scholar
- Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731–9. DOIPubMedGoogle Scholar
- Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol. 2007;7:214. DOIPubMedGoogle Scholar
- Balish AL, Davis CT, Saad MD, El-Sayed N, Esmat H, Tjaden JA, Antigenic and genetic diversity of highly pathogenic avian influenza A (H5N1) viruses isolated in Egypt. Avian Dis. 2010;54(Suppl):329–34. DOIPubMedGoogle Scholar
- Nguyen HT, Sheu TG, Mishin VP, Klimov AI, Gubareva LV. Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays. Antimicrob Agents Chemother. 2010;54:3671–7. DOIPubMedGoogle Scholar
- Duan L, Bahl J, Smith GJ, Wang J, Vijaykrishna D, Zhang LJ, The development and genetic diversity of H5N1 influenza virus in China, 1996–2006. Virology. 2008;380:243–54. DOIPubMedGoogle Scholar
- Smith GJ, Vijaykrishna D, Ellis TM, Dyrting KC, Leung YH, Bahl J, Characterization of avian influenza viruses A (H5N1) from wild birds, Hong Kong, 2004–2008. Emerg Infect Dis. 2009;15:402–7. DOIPubMedGoogle Scholar
- Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, Stech J. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A. 2005;102:18590–5. DOIPubMedGoogle Scholar
- Poole E, Elton D, Medcalf L, Digard P. Functional domains of the influenza A virus PB2 protein: identification of NP- and PB1-binding sites. Virology. 2004;321:120–33. DOIPubMedGoogle Scholar
- González S, Ortin J. Distinct regions of influenza virus PB1 polymerase subunit recognize vRNA and cRNA templates. EMBO J. 1999;18:3767–75. DOIPubMedGoogle Scholar
- Honda A, Mizumoto K, Ishihama A. Two separate sequences of PB2 subunit constitute the RNA cap-binding site of influenza virus RNA polymerase. Genes Cells. 1999;4:475–85. DOIPubMedGoogle Scholar
- Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science. 2006;312:404–10. DOIPubMedGoogle Scholar
- Baudin F, Petit I, Weissenhorn W, Ruigrok RW. In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology. 2001;281:102–8. DOIPubMedGoogle Scholar
- Lin D, Lan J, Zhang Z. Structure and function of the NS1 protein of influenza A virus. Acta Biochim Biophys Sin (Shanghai). 2007;39:155–62. DOIPubMedGoogle Scholar
- Obenauer JC, Denson J, Mehta PK, Su X, Mukatira S, Finkelstein DB, Large-scale sequence analysis of avian influenza isolates. Science. 2006;311:1576–80. DOIPubMedGoogle Scholar
- Watanabe Y, Ibrahim MS, Ellakany HF, Kawashita N, Mizuike R, Hiramatsu H, Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt. PLoS Pathog. 2011;7:e1002068. DOIPubMedGoogle Scholar
- Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science. 2001;293:1840–2. DOIPubMedGoogle Scholar
- Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med. 2002;8:950–4. DOIPubMedGoogle Scholar
- World Health Organization. Availability of a new recombinant A(H5N1) vaccine virus. 2011 [cited 2012 Jan 8]. http://www.who.int/influenza/vaccines/virus/h5n1virus_september/en/
- World Health Organization. Global Alert and Response (GAR). Avian influenza—situation in Egypt—update. 2012 [cited 2012 Nov 5]. http://www.who.int/csr/don/2012_02_22/en/index.html
- Cattoli G, Fusaro A, Monne I, Coven F, Joannis T, El-Hamid HS, Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry. Vaccine. 2011;29:9368–75. DOIPubMedGoogle Scholar
- El-Zoghby EF, Arafa AS, Hassan MK, Aly MM, Selim A, Kilany WH, Isolation of H9N2 avian influenza virus from bobwhite quail (Colinus virginianus) in Egypt. Arch Virol. 2012;157:1167–72. DOIPubMedGoogle Scholar
1These authors contributed equally to this article.